查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435416

2024 年植入式生物材料全球市場報告

Implantable Biomaterials Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年可植入生物材料的市場規模將快速成長。預計到 2028 年將以 10.9% 的複合年成長率 (CAGR) 成長至 2,179.8 億美元。預計的成長取決於生物活性/生物可吸收材料、智慧/響應性生物材料、監管/安全標準、混合材料和組織工程的進步。預期趨勢包括藥物釋放型植入、增強的生物相容性、3D 列印/客製化、專注於再生醫學以及奈米技術的整合。

政府對新型生物材料進步的投資是植入式生物材料市場成長的關鍵驅動力，德雷塞爾大學向國家科學基金會提供 20 萬美元的計劃津貼就證明了這一點。這種財政支持將有助於研究生物材料介導的對影響生物材料血管生成的巨噬細胞行為的控制。政府機構的支持將促進植入式生物材料的進一步發展。

心血管疾病的快速成長預計將推動植入式生物材料市場的擴張。以影響心臟和血管的疾病為特徵的心血管疾病呈上升趨勢，增加了對可植入生物材料的需求。這些材料在解決心血管問題方面發揮著至關重要的作用，並用於各種醫療設備和手術中以修復或替換受損組織。隨著心血管疾病盛行率的增加，對創新生物材料的需求至關重要，以改善患者的治療結果並提高生活品質。特別是，2022 年 3 月和 2023 年 5 月的統計數據突顯了問題的嚴重性，分別引用了英國和美國心臟病發作的死亡人數和心血管疾病的盛行率。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球植入生物材料市場，依材料、性能及預測細分，2018-2023、2023-2028、2033
  • 金屬的
  • 陶瓷製品
  • 聚合物
  • 自然的
  • 全球植入生物材料市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 牙科
  • 心血管
  • 眼科
  • 整形外科
  • 其他用途
  • 全球植入生物材料市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院
  • 門診手術中心
  • 專科診所

第 7 章 區域與國家分析

  • 全球植入生物材料市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球植入生物材料市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 植入式生物材料市場競爭形勢
  • 植入式生物材料市場公司概況
    • BASF SE
    • 3M Company
    • Medtronic plc
    • Evonik Industries AG
    • Stryker Corporation

第31章 其他大型創新公司

  • DuPont de Nemours Inc.
  • Celanese Corporation
  • Zimmer Biomet Holdings Inc.
  • Biomet Inc.
  • Koninklijke DSM NV
  • Arthrex Inc.
  • DePuy Synthes Companies
  • Carpenter Technology Corporation
  • Corbion NV
  • GELITA AG
  • Wright Medical Group NV
  • CoorsTek Inc.
  • CeramTec GmbH
  • Orthofix Holdings Inc.
  • Invibio Biomaterial Solutions plc

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r15134

Implantable biomaterials are natural or synthetic materials utilized in medical applications to support, enhance, or replace damaged tissues or biological structures.

These materials encompass metallic, ceramic, polymers, and natural substances. Metallic implants, often preferred in orthopedic prosthesis, enhance biological activities and are favored over polymeric and traditional ceramic biomaterials. They find applications in dental, cardiovascular, ophthalmology, orthopedic, and other medical fields, used across hospitals, ambulatory surgical centers, and specialty clinics.

The implantable biomaterials market research report is one of a series of new reports from The Business Research Company that provides implantable biomaterials market statistics, including implantable biomaterials industry global market size, regional shares, competitors with an implantable biomaterials market share, detailed implantable biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the implantable biomaterials industry. This implantable biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The implantable biomaterials market size has grown rapidly in recent years. It will grow from $127.97 billion in 2023 to $144.1 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth observed in the historic period can be attributed to several factors, including clinical success leading to positive patient outcomes, advancements in tissue engineering, development of surface modification techniques, achieving significant regulatory milestones, and the introduction of biodegradable materials in this field.

The implantable biomaterials market size is expected to see rapid growth in the next few years. It will grow to $217.98 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. Forecasted growth relies on bioactive/bioresorbable materials, smart/responsive biomaterials, regulatory/safety standards, hybrid composites, and tissue engineering advancements. Anticipated trends include drug-eluting implants, enhanced biocompatibility, 3D printing/customization, regenerative medicine focus, and nanotechnology integration.

Government organizations' investment in the advancement of new biomaterials, as evidenced by allocations to projects such as Drexel University's USD 200,000 grant to the National Science Foundation, is a significant driver of growth in the implantable biomaterials market. This financial support fosters research on biomaterial-mediated control over macrophage behavior, influencing biomaterial vascularization. The backing from government entities is poised to fuel further advancements in implantable biomaterials.

The surge in instances of cardiovascular diseases is anticipated to propel the expansion of the implantable biomaterial market. Characterized by conditions impacting the heart and blood vessels, cardiovascular diseases are on the rise, creating a heightened demand for implantable biomaterials. These materials play a pivotal role in addressing cardiovascular issues, employed in various medical devices and procedures to repair or replace damaged tissues. As the prevalence of cardiovascular problems increases, the necessity for innovative biomaterials becomes paramount, aiming to enhance patient outcomes and improve their quality of life. Notably, statistics from March 2022 and May 2023 underscore the magnitude of the issue, citing the number of deaths attributed to heart attacks and the prevalence of cardiovascular diseases in the UK and the United States, respectively.

The implantable biomaterials market faces substantial challenges due to limitations associated with biomaterial-based products. Notably, metal biomaterials can undergo corrosion within the body, triggered by chemical reactions such as enzymatic and acidic processes, potentially leading to metal ion toxicity. Similarly, polymer biomaterial implants exhibit intensive interaction with the body, resulting in wear and tear and the absorption of essential nutrients and water from the blood. Additionally, certain biomaterial implants may hinder bone ingrowth, experience loosening over time, or become dislodged, thereby restricting their utility and exerting a negative influence on the growth of the implantable biomaterials market.

Leading companies in the implantable biomaterial market are strategically directing their efforts towards the development of cutting-edge technology and products rooted in biomaterial technology, particularly for orthopaedic surgical applications. Biomaterial technology, a discipline encompassing the development, design, and application of materials interacting with biological systems, serves as a focal point for innovation. An exemplar is Acuitive Technologies Inc., a US-based medical device manufacturer, which introduced CITREGEN in September 2021. CITREGEN, a biomaterial technology, is utilized in musculoskeletal surgeries, enhancing outcomes for patients. This innovative device facilitates the attachment of soft tissue grafts to bone in reconstruction surgeries, featuring a distinctive design. CITREGEN's chemical and mechanical properties, including citrate, phosphate, and calcium, make it well-suited for orthopaedic surgical applications. Notably, CITRELOCK, an implantable device derived from CITREGEN, exhibits compressive strength comparable to cortical bone, maintaining structural integrity throughout the healing phase. This pioneering technology represents the first thermoset biodegradable synthetic polymer employed in implantable medical devices.

In April 2022, Integer Holdings Corporation, a U.S.-based medical device company, successfully acquired Connemara Biomedical Holdings Teoranta for an undisclosed sum. This strategic acquisition positions Integer to control implantable biomaterial technology, fostering its growth in the medical device industry. Connemara Biomedical Holdings Teoranta, based in Ireland, specializes in the manufacturing of biomaterials for cardiovascular implants.

Major companies operating in the implantable biomaterials market report are BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation; DuPont de Nemours Inc.; Celanese Corporation; Zimmer Biomet Holdings Inc.; Biomet Inc.; Koninklijke DSM NV; Arthrex Inc.; DePuy Synthes Companies; Carpenter Technology Corporation; Corbion NV; GELITA AG; Wright Medical Group NV; CoorsTek Inc.; CeramTec GmbH; Orthofix Holdings Inc.; Invibio Biomaterial Solutions plc; Keystone Dental Inc.; KLS Martin SE & Co.; Collagen Matrix Inc.; Cam Bioceramics BV; Aap Implantate AG; Berkeley Advanced Biomaterials Inc.; AdvanSource Biomaterials Corporation; Collagen Solutions plc; Surgival SL; SBM France SAS

North America was the largest region in the implantable biomaterials market in 2023. Western Europe was the second largest region in the global implantable biomaterials market report. The regions covered in the implantable biomaterials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the implantable biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The implantable biomaterial market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Biomaterials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable biomaterials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable biomaterials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable biomaterials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Material: Metallic; Ceramic; Polymers; Natural
  • 2) By Application: Dental; Cardiovascular; Ophthalmology; Orthopedic; Other Applications
  • 3) By End-user: Hospitals; Ambulatory Surgical Centers; Specialty Clinics
  • Companies Mentioned: BASF SE; 3M Company; Medtronic plc; Evonik Industries AG; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Biomaterials Market Characteristics

3. Implantable Biomaterials Market Trends And Strategies

4. Implantable Biomaterials Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Implantable Biomaterials Market Size and Growth

  • 5.1. Global Implantable Biomaterials Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Implantable Biomaterials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Implantable Biomaterials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Implantable Biomaterials Market Segmentation

  • 6.1. Global Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Metallic
  • Ceramic
  • Polymers
  • Natural
  • 6.2. Global Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dental
  • Cardiovascular
  • Ophthalmology
  • Orthopedic
  • Other Applications
  • 6.3. Global Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

7. Implantable Biomaterials Market Regional And Country Analysis

  • 7.1. Global Implantable Biomaterials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Implantable Biomaterials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Implantable Biomaterials Market

  • 8.1. Asia-Pacific Implantable Biomaterials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Implantable Biomaterials Market

  • 9.1. China Implantable Biomaterials Market Overview
  • 9.2. China Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Implantable Biomaterials Market

  • 10.1. India Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Implantable Biomaterials Market

  • 11.1. Japan Implantable Biomaterials Market Overview
  • 11.2. Japan Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Implantable Biomaterials Market

  • 12.1. Australia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Implantable Biomaterials Market

  • 13.1. Indonesia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Implantable Biomaterials Market

  • 14.1. South Korea Implantable Biomaterials Market Overview
  • 14.2. South Korea Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Implantable Biomaterials Market

  • 15.1. Western Europe Implantable Biomaterials Market Overview
  • 15.2. Western Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Implantable Biomaterials Market

  • 16.1. UK Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Implantable Biomaterials Market

  • 17.1. Germany Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Implantable Biomaterials Market

  • 18.1. France Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Implantable Biomaterials Market

  • 19.1. Italy Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Implantable Biomaterials Market

  • 20.1. Spain Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Implantable Biomaterials Market

  • 21.1. Eastern Europe Implantable Biomaterials Market Overview
  • 21.2. Eastern Europe Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Implantable Biomaterials Market

  • 22.1. Russia Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Implantable Biomaterials Market

  • 23.1. North America Implantable Biomaterials Market Overview
  • 23.2. North America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Implantable Biomaterials Market

  • 24.1. USA Implantable Biomaterials Market Overview
  • 24.2. USA Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Implantable Biomaterials Market

  • 25.1. Canada Implantable Biomaterials Market Overview
  • 25.2. Canada Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Implantable Biomaterials Market

  • 26.1. South America Implantable Biomaterials Market Overview
  • 26.2. South America Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Implantable Biomaterials Market

  • 27.1. Brazil Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Implantable Biomaterials Market

  • 28.1. Middle East Implantable Biomaterials Market Overview
  • 28.2. Middle East Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Implantable Biomaterials Market

  • 29.1. Africa Implantable Biomaterials Market Overview
  • 29.2. Africa Implantable Biomaterials Market, Segmentation By Material, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Implantable Biomaterials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Implantable Biomaterials Market, Segmentation By End-user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Implantable Biomaterials Market Competitive Landscape And Company Profiles

  • 30.1. Implantable Biomaterials Market Competitive Landscape
  • 30.2. Implantable Biomaterials Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. 3M Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Evonik Industries AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Stryker Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Implantable Biomaterials Market Other Major And Innovative Companies

  • 31.1. DuPont de Nemours Inc.
  • 31.2. Celanese Corporation
  • 31.3. Zimmer Biomet Holdings Inc.
  • 31.4. Biomet Inc.
  • 31.5. Koninklijke DSM NV
  • 31.6. Arthrex Inc.
  • 31.7. DePuy Synthes Companies
  • 31.8. Carpenter Technology Corporation
  • 31.9. Corbion NV
  • 31.10. GELITA AG
  • 31.11. Wright Medical Group NV
  • 31.12. CoorsTek Inc.
  • 31.13. CeramTec GmbH
  • 31.14. Orthofix Holdings Inc.
  • 31.15. Invibio Biomaterial Solutions plc

32. Global Implantable Biomaterials Market Competitive Benchmarking

33. Global Implantable Biomaterials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Implantable Biomaterials Market

35. Implantable Biomaterials Market Future Outlook and Potential Analysis

  • 35.1 Implantable Biomaterials Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Implantable Biomaterials Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Implantable Biomaterials Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer